Technical Analysis for CVKD - Cadrenal Therapeutics, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | N/A | N/A | N/A |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| New 52 Week Closing Low | Bearish | 0.00% | |
| Hot IPO Pullback | Bullish Swing Setup | 0.00% | |
| New 52 Week Low | Weakness | 0.00% | |
| Gapped Up | Strength | 0.00% | |
| Down 3 Days in a Row | Weakness | 0.00% | |
| New 52 Week Closing Low | Bearish | -2.07% | |
| Hot IPO Pullback | Bullish Swing Setup | -2.07% | |
| New 52 Week Low | Weakness | -2.07% | |
| Gapped Down | Weakness | -2.07% | |
| New 52 Week Closing Low | Bearish | -11.25% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
| Alert | Time |
|---|---|
| Hot IPO Pullback Entry | about 9 hours ago |
| Rose Above Previous Day's High | about 9 hours ago |
| New 52 Week High | about 9 hours ago |
| Outside Day | about 9 hours ago |
| Up 5% | about 9 hours ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: ???
Cadrenal Therapeutics, Inc. operates as a clinical development biopharmaceutical company. The company focuses on developing Tecarfarin, a novel therapy with orphan drug indication for the prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fibrillation. The company was incorporated in 2022 and is headquartered in Ponte Vedra, Florida.
Keywords: Health Sciences Hematology End Stage Renal Disease Cardiac Arrhythmia Atrial Fibrillation Venous Thrombosis
Classification
Keywords: Health Sciences Hematology End Stage Renal Disease Cardiac Arrhythmia Atrial Fibrillation Venous Thrombosis
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 6.1 |
| 52 Week Low | 2.8 |
| Average Volume | 567,075 |
| 200-Day Moving Average | 0.00 |
| 50-Day Moving Average | 0.00 |
| 20-Day Moving Average | 0.00 |
| 10-Day Moving Average | 0.00 |
| Average True Range | 0.00 |
| RSI | 0.00 |
| ADX | 0.0 |
| +DI | 0.00 |
| -DI | 0.00 |
| Chandelier Exit (Long, 3 ATRs) | N/A |
| Chandelier Exit (Short, 3 ATRs) | N/A |
| Upper Bollinger Bands | 0.00 |
| Lower Bollinger Band | 0.00 |
| Percent B (%b) | 0.0 |
| BandWidth | 0.00 |
| MACD Line | 0.00 |
| MACD Signal Line | 0.00 |
| MACD Histogram | 0.0 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 3.26 | ||||
| Resistance 3 (R3) | 3.29 | 3.19 | 3.19 | ||
| Resistance 2 (R2) | 3.19 | 3.08 | 3.17 | 3.17 | |
| Resistance 1 (R1) | 3.01 | 3.01 | 2.96 | 2.98 | 3.14 |
| Pivot Point | 2.91 | 2.91 | 2.88 | 2.89 | 2.91 |
| Support 1 (S1) | 2.73 | 2.80 | 2.68 | 2.70 | 2.54 |
| Support 2 (S2) | 2.63 | 2.73 | 2.61 | 2.51 | |
| Support 3 (S3) | 2.45 | 2.63 | 2.49 | ||
| Support 4 (S4) | 2.42 |
